Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ8548550,00
KB869870-0,23
PKN67,3567,37-0,49
Msft409409,30,40
Nokia3,43153,43450,66
IBM183,69184,181,01
Mercedes-Benz Group AG73,9874-0,08
PFE26,3326,340,04
24.04.2024 13:54:00
Indexy online
AD Index online
select
AD Index online
 

  • 24.04.2024 13:47:14
Richter Gedeon (Budapest)
Poslední obchod Změna (%) Změna (HUF) Objem obchodů (HUF)
8 990,00 0,33 30,00 644 720 210
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 24.04.2024
Popis společnosti
Obecné informace
Název společnostiRichter Gedeon Vegyeszeti Gyar Nyrt
TickerRICHTER
Kmenové akcie:Ordinary Shares
Kmenové akcie:Ordinary Shares
RICGDRB.BU
ISINHU0000123096
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 31.12.2022 12 167
Akcie v oběhu k 31.12.2023 183 184 738
MěnaHUF
Kontaktní informace
UliceGyomroi ut 19-21.
MěstoBUDAPEST
PSČ1103
ZeměHungary
Kontatní osoba 
Funkce kontaktní osoby 
Telefon3 614 314 027
Fax3612604891

Business Summary: Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Richter Gedeon Vegyeszeti Gyar Nyrt revenues increased less than 1% to HUF805.16B. Net income decreased 6% to HUF158.85B. Revenues reflect market conditions. Net income was partially offset by Realised exchange gain/loss on trade re decrease from HUF24.64B (income) to HUF39.03B (expense), Administration and general expenses increase of 45% to HUF50.57B (expense).
Odvětvová klasifikace
TRBC2012Generic Pharmaceuticals
RBSS2004Pharmaceuticals - Diversified
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICSDrugs and Druggists' Sundries Merchant Wholesalers
NAICSPharmacies and Drug Retailers
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Drugs and Druggists' Sundries Merchant Wholesalers
NAICS2007Pharmacies and Drug Stores
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Drug, Drug Proprietaries and Druggists' Sundries Wholesalers
NAICS1997Pharmacies and Drug Stores
SICPharmaceutical Preparations
SICDrugs/proprietaries/sundries
SICDrug Stores/proprietary Stores



  • Poslední aktualizace: 24.04.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board of Directors, Member of the Executive BoardErik Bogsch7401.11.2017
Independent Chairman of the Supervisory BoardAttila Chikan7901.01.2000
Chief Executive Officer, Member of the Executive Board, Member of the Board of DirectorsGabor Orban4401.11.201701.11.2017
Deputy Chief Executive Officer, Chief Financial Officer, Member of the Executive Board, DirectorIstvan Hamecz5612.04.202212.04.2022
Director of Human Resources, Member of the Executive BoardKatalin Erdei49
Member of the Executive Board, Research DirectorIstvan Greiner63
Member of the Executive Board, Commercial DirectorTibor Horvath4901.01.2017
Member of the Executive Board, Director of pharmaceutical manufacturingAttila Szenasi39
Regulatory Science Director, Member of the Executive BoardTamas Szolyak5701.01.2022